Data_Sheet_1_Associations of the miRNA-146a rs2910164 and the miRNA-499a rs3746444 Polymorphisms With Plasma Lipid Levels: A Meta-Analysis.docx by Fuqiang Liu (451879)

“…The standardized mean difference (SMD) and 95% confidence interval (CI) were used to evaluate the differences in lipid levels between the genotypes. rs2910164, a functional polymorphism in the miRNA-146a gene, was associated with increased triglycerides (TG) (SMD = 0.35, 95% CI = 0.15–0.54, p < 0.001), total cholesterol (TC) (SMD = 0.43, 95% CI = 0.16–0.70, p < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = 0.37, 95% CI = 0.11–0.63, p = 0.01) as well as decreased high-density lipoprotein cholesterol (HDL-C) (SMD = −0.27, 95% CI = −0.47−0.07, p = 0.01) levels. rs3746444, a functional polymorphism in the miRNA-499a gene, was only correlated with decreased TG (SMD = −0.09, 95% CI = −0.17−0.01, P = 0.03) levels.…”

Placentome morphology and fetal weight. by Ellane R. Cleys (692077)

“…<p><b>A</b>) Testosterone propionate treatment (TP) decreased the number of type A placentomes, and increased type C and type D placentomes collected at gestational day 90. …”

tRA-mediated decrease of lymphocyte accumulation in the MLN. by Xiaofeng Liao (177516)

HSP90 inhibitors decrease LMP1 expression. by Takayuki Murata (196417)

Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

Lytic reactivation stimuli decrease Oct-2 expression. by Amanda R. Robinson (184305)

“…<p>(A) The EBV-negative B-cell line, Akata (-), and the EBV-positive B-cell line, Akata-EBV+, were lytically induced with anti-IgG (20 µg/mL). …”

The ω Subunit of RNA Polymerase Is Essential for Thermal Acclimation of the Cyanobacterium <i>Synechocystis</i> Sp. PCC 6803 by Liisa Gunnelius (658400)

“…<div><p>The <i>rpoZ</i> gene encodes the small ω subunit of RNA polymerase. A ΔrpoZ strain of the cyanobacterium <i>Synechocystis</i> sp. …”

RQ₁₀ and Q₁₀ production (pmol/mg wet pellet) in <i>R</i>. <i>rubrum</i> mutant strains from LC-MS analysis. by Amanda R. M. Campbell (6719102)

“…<p>A. Anaerobic growth conditions with RQ₁₀ production designated with dark grey bars and Q₁₀ with light grey bars. …”

Comparison of a 12-month post-surgical follow up to the baseline data. by Orna Avlas (446424)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”

Macrophage-secreted factors decrease RBP4 production. by Primoz Kotnik (382835)

The ratios of SAP to DNA decrease in SLE murine model. by Weijuan Zhang (347468)

Differential levels of epigenetic regulators with TP treatment. by Ellane R. Cleys (692077)

“…<p>Analysis of relative mRNA levels for genes regulating histone and DNA methylation and imprinting in ovine placentome tissue from real time PCR. <i>KDM4C</i> was decreased in type A placentomes from TP treated ewes compared to controls. …”

miR-24 levels decrease with replicative senescence. by Ashish Lal (43926)

EsA protected against GalN/LPS-induced histopathological damage and hepatic dysfunction. by Fang Zhang (197215)

“…Levels of AST and ALT increased obviously after GalN/LPS challenge, and which were significantly decreased with EsA treatment (n = 6 C). The values presented are the means ± standard error of the mean. …”

Summary of WetA functions and a model for WetA-mediated developmental regulation in <i>A</i>. <i>flavus</i>. by Ming-Yueh Wu (630764)

“…In this model, those genes with increased and decreased mRNA levels in the Δ<i>wetA</i> conidia are labeled in yellow (WetA-inhibited) and blue (WetA-activated), respectively. …”

Kinases and Phosphatases that decrease the ratio of p-syn/t-syn. by Adrienne Henderson-Smith (478169)

Expression levels of genes involved in glycolysis upon treatment with 10058-F4. by Muhammad Mushtaq (788834)

“…<p>Expression levels of a set of genes (<i>GLUTI</i>, <i>HK</i>, <i>LDHA</i>, <i>MCT4</i>, <i>PDK1</i>, <i>PGK1</i>, and <i>PKM2</i>) were assessed by Q-PCR after the treatment of cells with 100 μM of 10058-F4 for 4 h. …”

EsA protected against CCl₄-induced histopathological damage and hepatic dysfunction. by Fang Zhang (197215)

“…However, AST and ALT levels did not markedly increase in mice treated with EsA alone, and AST and ALT levels were significantly decreased with EsA treatment. …”

Reduced muscle performance gain and hypertrophy and decrease in contractile by Pierre Joanne (171616)